ClinicalTrials.Veeva

Menu

VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain

Northwestern University logo

Northwestern University

Status

Enrolling

Conditions

Pain, Chronic

Treatments

Other: Experimental: Group #1: Virtual Reality Headset
Other: Group 2 No Virtual Reality Headset

Study type

Interventional

Funder types

Other

Identifiers

NCT06336447
STU00220295

Details and patient eligibility

About

This study will examine the impact of virtual reality used in conjunction with sedation compared to sedation alone in patients undergoing watervcooled genicular nerve ablations for chronic knee pain.

The goals of the study is to determine the relative efficacy of virtual reality as a distraction modality when used as an adjuvant to procedural sedation compared to sedation alone for procedure related pain. To assess procedural satisfaction, and 1-month pain and functional outcomes.To explore whether virtual reality and lower procedure-related pain scores affect 1-month outcomes. And finally to determine whether demographic and clinical characteristics are associated with outcome measures.

Enrollment

62 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing genicular RFA will be eligible for inclusion in the study
  • Patients with knee pain, baseline average of > 4/10
  • X-ray evidence of osteoarthritis of the knee
  • Pain duration of >6 weeks and no previous knee surgeries
  • Patients will also only be included who have never undergone a RFA on the affected knee

Exclusion criteria

  • Individuals who do not have evidence of osteoarthritis on X-ray,
  • Secondary gain expected to influence treatment outcomes
  • Poorly controlled psychiatric condition that could affect outcome (e.g. active substance abuse) or impose a barrier to participation
  • Chronic opioid use and anticoagulation therapy that cannot be stopped and could warrant a different treatment approach (e.g. phenol ablation)
  • Severe motion sickness
  • Seizure disorder
  • Vision loss
  • Pregnant
  • Nursing

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

62 participants in 2 patient groups

Group #1: Virtual Reality Headset
Experimental group
Description:
Group 1 will be assigned to the Virtual Realtity Headset. Participants will wear the headset for at least 10 minutes prior to the planned procedure. Subjects will receive standard procedure. The VR Headset will be removed 10 minutes after the planned procedure.
Treatment:
Other: Experimental: Group #1: Virtual Reality Headset
Group 2 No Virtual Reality Headset
Active Comparator group
Description:
Group 2 will receive standard care without the use of the Virtuality Reality Headset.
Treatment:
Other: Group 2 No Virtual Reality Headset

Trial contacts and locations

1

Loading...

Central trial contact

Paul Fitzgerald, RN,BSN,MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems